Clinical Trial Update: Shortening Duration of Antiarrhythmic Medication for SVT in Infants

View source ↗

Summary

A completed clinical trial evaluated whether shortening the duration of antiarrhythmic therapy is feasible for infants with supraventricular tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Supraventricular Tachycardia

Snippet

Sponsor: Tampere University Hospital | Conditions: Supraventricular Tachycardia | Status: COMPLETED